- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03675204
Establishment of the Breast Milk Database in China
Study Overview
Detailed Description
The study cities are Guangzhou, Weihai, Chengdu, Beijing, Harbin, Wuhan, Jinhua, Zhengzhou and Lanzhou.
Breast milk will be collected at 9:00-11:00 in the morning from 15 to180 days after giving birth. The nutrients (protein, triglyceride, phospholipid, oligosaccharides and probiotics) in the collected breast milk samples will be measured. These data will be used to establish the breast milk database in China. This databased will provide references for infant nutrient intake and for the formulation and revision of infant formula standards. It will also provide references for the development of new infant formula products in China.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Lactating mother 25 ~ 35 years old;
- Breast-feeding infants (15 ~180 days old );
- Physically healthy by self-evaluation;
- Does not smoke;
- Does not drink alcohol;
- Have given birth to physically healthy infants;
- Signed the informed consent forms.
Exclusion Criteria:
- Being treated for gastrointestinal symptoms;
- Suffering from mastitis;
- Suffering from infectious diseases (tuberculosis, viral hepatitis and HIV infection);
- Suffering from cardiovascular disease;
- Suffering from metabolic diseases (such as diabetes);
- Suffering from mental system diseases;
- Suffering from cancer and other malignant diseases;
- Having history of taking antibiotics;
- Not able to answer the study questions;
- Participating in any nutritional or pharmaceutical intervention study recently.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Protein in breast milk
Time Frame: At enrollment
|
Protein in breast milk measured in percent (%)
|
At enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Osmotic pressure
Time Frame: At enrollment
|
Osmotic pressure (mmolOsm/Lkg.H2O) in breast milk
|
At enrollment
|
|
Fatty acids in breast milk
Time Frame: At enrollment
|
Fatty acids composition (mg/L) in breast milk
|
At enrollment
|
|
Amino acids
Time Frame: At enrollment
|
Amino acids composition (mg/L) in breast milk
|
At enrollment
|
|
Oligosaccharides
Time Frame: At enrollment
|
Oligosaccharides levels (mg/L) in breast milk
|
At enrollment
|
|
Probiotics
Time Frame: At enrollment
|
Probiotics composition (species) measured using gene sequencing in breast milk;
|
At enrollment
|
|
Vitamins
Time Frame: At enrollment
|
Vitamins composition (μg/L) in breast milk
|
At enrollment
|
|
Minerals
Time Frame: At enrollment
|
Minerals composition (mg/L) in breast milk
|
At enrollment
|
|
Hormones
Time Frame: At enrollment
|
Hormones composition (mg/L) in breast milk
|
At enrollment
|
|
Dietary composition of participating mothers
Time Frame: At enrollment
|
Investigation on the dietary composition of participating mothers obtained using questionnaire
|
At enrollment
|
|
Height of participating mothers
Time Frame: At enrollment
|
Height measurement (cm) of participating mothers
|
At enrollment
|
|
Weight of participating mothers
Time Frame: At enrollment
|
Body weight measurement (kg) of participating mothers
|
At enrollment
|
|
Age of participating mothers
Time Frame: At enrollment
|
Age (years) of participating mothers obtained using questionnaire
|
At enrollment
|
|
Educational level of participating mothers
Time Frame: At enrollment
|
Educational level of participating mothers obtained using questionnaire
|
At enrollment
|
|
Occupation of participating mothers
Time Frame: At enrollment
|
Occupation of participating mothers obtained using questionnaire
|
At enrollment
|
|
Physical health condition of participating mothers
Time Frame: At enrollment
|
Physical health condition of participating mothers assessed by questionnaire
|
At enrollment
|
|
Triglyceride
Time Frame: At enrollment
|
Triglyceride (mg/g) contents in breast milk
|
At enrollment
|
|
Phospholipid
Time Frame: At enrollment
|
Phospholipid (mg/g) contents in breast milk
|
At enrollment
|
Collaborators and Investigators
Investigators
- Study Director: Shilong Jiang, Heilongjiang Feihe Dairy Co. Ltd.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 16-SC-05-FC-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Milk Collection
-
Ospedale Buon Consiglio FatebenefratelliUniversity of SalernoRecruiting
-
Heilongjiang Feihe Dairy Co. Ltd.Recruiting
-
Chinese University of Hong KongUnknown
-
EnzymotecCompletedBreast Milk CollectionIsrael
-
Washington State UniversityUnknownBreast Milk CollectionUnited States
-
Istanbul UniversityRecruiting
-
Vilnius UniversityUniversity of CagliariCompleted
-
University of TurkuCompleted
-
Zhujiang HospitalRecruitingHealthy | Feces | Breast-milk CollectionChina
-
Aga Khan UniversityThe Hospital for Sick Children; University of TorontoCompletedInfant Development | Breast Milk CollectionPakistan
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown